Papers: 10.3389/fimmu.2021.730320

https://doi.org/10.3389/fimmu.2021.730320

Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis

Cited by: 31
Author(s): Qing Zhao, Jianwei Zhang, Lingyi Xu, Huaxia Yang, Ning Liang, Li Zhang, Fengchun Zhang, Xuan Zhang
Published: about 5 years ago

Software Mentions 1